| 22900 | NARCAG | Narcolepsy Associated Antigen (NARC) | Ref Lab Code: 82026, Narcolepsy Associated Ag, B | | | 23294 | NASHSO | NASH FibroSURE (550140) | Fatty Liver Disease, NAFLD, Nonalcoholic Fatty Liver Disease, Noninvasive Liver Biopsy, Steatohepatitis | a2-macroglobulin, haptoglobin, apolipoprotein A1, bilirubin, y-glutamyl transpeptidase (GGT), alanine aminotransferase (ALT), aspartate aminotransferase (AST), total cholesterol, triglycerides, and fasting glucose | | 25063 | NK | Natural Killer (CD16, CD56, CD57) Profile | Flow Cytometry | | | 23232 | | Natural Killer Cells | Flow Cytometry, Killer Cells | | | 22901 | GC-NAM | Neisseria Gonorrhoeae, Nucleic Acid Method (NAM) | Neisseria gonorrhoea, Gonorrhea, GC | | | 25223 | NEO | Neonatal Screen (281) | PKU-Newborn Screening, CAH Trypsinogen Screen, Newborn Screening | | | 24742 | | Neonate Transfusion | Neonate type and screen, Newborn type and screen, Newborn transfusion, Quad pack, BBNBSCN, Newborn Type & AbScn & DAT | ABO/RH, DAT, ABSC, may include Weak D. | | 25072 | NEOPTSO | Neopterin (FNEOP) | Ref Lab Code: 91285, Neopterin, Serum | | | 25597 | NMOFSSO | Neuromyelitis Optica (NMO)/Aquaporin-4-IgG Fluorescence-Activated Cell Sorting (FACS) Assay, Serum | NMO/AQP4 FACS Assay with reflex to Titer | When the results of this assay require further evaluation, NMOTS/Neuromyelitis Optica (NMO)/Auaporin-4-IgG Fluorescence-Activated Cell Sorting (FACS) Titer Assay, Serum will be performed at an additional charge. | | 22904 | NSESO | Neuron-Specific Enolase (NSE) | NSE Enolase | | | 26294 | NONCPSO | Neuro-Oncology Expanded Gene Panel with Rearrangement, Tumor (NONCP) | ATRX
BRAF
Brain tumor
Central nervous system (CNS) cancers
EGFR
H3F3A
HIST1H3B
HIST1H3C
IDH1
IDH2
Next Gen Sequencing Test
NGS
Oncology panel
RELA
SMARCA4
SMARB1
TERT | | | 26017 | NGSAMSO | Next-Gen Sequencing, Acute Myeloid Leukemia(NGAML) | FLT3, NPM1, CEPBA, IDH1, IDH2, KRAS, NRAS, TP53, Next generation sequencing of leukemia, Next Gen Sequencing Test, NGS for acute myeloid leukemia evaluation, NGS hematologic malignancies, Somatic mutation detection by next generation sequencing (NGS), hematologic, DNMT3A, KIT, RUNX1, NGAML | This test includes next-generation sequencing to evaluate for the following 11 genes: CEBPA, DNMT3A, FLT3, IDH1, IDH2, KIT, KRAS, NPM1, NRAS, RUNX1, and TP53. | | 26018 | NGSHMSO | Next-Gen Sequencing, Hematologic Neoplasms (NGSHM) | NGS hematologic malignancies, NGS cancer panel, hematologic, Somatic mutation detection by next generation sequencing (NGS), hematologic, Next gen sequencing of leukemia (AML) and myelodysplasia (MDS), NGS for myeloid neoplasm evaluation (MPN), Next Gen Sequencing Test, ASXL1, BCOR, CALR, CBL, CEBPA, CSF3R, DNMT3A, ETV6, EZH2, FLT3, GATA1, GATA2, IDH1, IDH2, JAK2, KIT, KRAS, MPL, NPM1, NRAS, PHF6, PTPN11, RUNX1, SETBP1, SF3B1, SRSF2, TERT, TET2, TP53, U2AF1, WT1, ZRSR2, ANKRD26, DDX41, ELANE, ETNK1, KDM6A, RAD21, SH2B3, SRP72, SMC3, STAG2 | This test includes next-generation sequencing to evaluate for the following 42 genes and select intronic regions: ANKRD26, ASXL1, BCOR, CALR, CBL, CEBPA, CSF3R, DDX41, DNMT3A,ELANE, ETNK1, ETV6, EZH2, FLT3, GATA1, GATA2, IDH1, IDH2, JAK2, KDM6A, KIT, KRAS, MPL, NPM1, NRAS, PHF6, PTPN11, RAD21, RUNX1, SETBP1, SH2B3, SF3B1, SRP72, SMC3, SRSF2, STAG2,TERT, TET2, TP53, U2AF1, WT1, and ZRSR2. | | 25045 | NICTS | Nicotine and Metabolites, Serum | Cotinine, Nicotine Metabolite, 3-OH-cotinine, trans-3-hydroxycotinine, trans-3-OH-cotinine | | | 26128 | NICOSSO | Nicotine and Metabolites, Serum (NICOS) | Cotinine, Tobacco Alkaloids | Nicotine, Cotinine | | 26296 | CO-NICT | Nicotine and Metabolites, Urine Confirm only by LCMSMS | | This is a quantitative urine test utilizing Liquid Chromatography/Tandem Mass Spectrometry (LCMS/MS) using Multiple Reaction Monitoring to determine presence and concentration of nicotine and cotinine. | | 25594 | NMDARSO | N-methyl-D-Aspartate Receptor Antibody, IgG, CSF with Reflex to Titer (2005164) | Anti-NMDA CSF, Glutamate Receptor Antibodies, N-Methyl D-Aspartate Ab CSF, NMDA R, NMDA Receptor Ab CSF | | | 26197 | NMH24SO | N-Methylhistamine, 24 hr U (NMH24) | 1-Methylhistamine
Histamine Metabolites
Urinary N-Methylhistamine | N-Methylhistamine, 24 Hr, U Creatinine, 24 Hr, U | | 26198 | NMHRSO | N-Methylhistamine, Urine (NMHR) | 1-Methylhistamine
Histamine Metabolites
Urinary N-Methylhistamine | N-Methylhistamine, Random Creatinine, Random, U | | 24994 | NMOESO | NMO/AQP4-IgG Cell Binding Assay (NMOCS) | AQP, AQP4, Aquaporin, Devic's Antibody, NMO (Neuromyelitis Optica), NMO-IgG, Optic Neuritis Antibody, Transverse Myelitis Antibody, Vision Loss Antibody | | | 23145 | NMRLISO | NMR Lipoprotein Quant 123638 | NMR, Small dense LDL, HDL-C | Historical reporting (LDL-P, LDL-C); insulin resistance and diabetes risk markers (large VLDL-P, small LDL-P, large HDL-P, VLDL size, LDL size, HDL size); insulin-resistance score; lipoprotein particle number (LDL-P); particle concentration and size (total HDL-P, small LDL-P, LDL size); standard lipid panel (total cholesterol, calculated LDL cholesterol, HDL cholesterol, triglycerides). | | 26133 | LNOROSO | Norovirus PCR, Feces (LNORO) | Norwalk virus | | | 22906 | NORTSO | Nortriptyline (NOTRP) | Aventyl (Nortriptyline), Serum, Nortriptyline, Serum, Pamelor (Nortriptyline), Serum, Sensoval, Aventyl, Pamelor, Norpress, Allegron, and Nortrilen (Nortriptyline), TCA (Tricyclic Antidepressants), Tricyclic Antidepressants (TCA) | | | 25075 | NPMCBSO | NPM1 Mutation with CEBPA Analysis if Needed (4637) | Ref Lab Code: 4637 | | | 23225 | NTXBSO | N-Telopeptide X-Link, Serum (SNTX) | NTx Serum | N-Terminal Telolpeptide | | 25647 | PBNPSO | NT-Pro-B Type Natriuretic Peptide (PBNP) | N Termial proNP, NT Pro BNP, ProBNP (B-Type Natriuretic Peptide) | | | 22907 | NTXSO | NTX-Telopeptide, Urine (NTXPR) | Collagen Crosslinks
Crosslinked N-telopeptide of Type I Collagen (NTX), Urine
N-Telopeptide, Urine
NTX Creatinine
Osteomark
Osteoporosis | |
|